1. Preface

• 1.1 Report Description and Scope

• 1.2 Research Objectives

• 1.3 Key Assumptions and Limitations

• 1.4 Target Audience

2. Executive Summary

• 2.1 Market Overview and Snapshot

• 2.2 Key Market Findings and Highlights

• 2.3 Market Size Estimation and Forecast Summary

• 2.4 Key Trends at a Glance

• 2.5 Recommendations for Market Participants

3. Research Methodology

• 3.1 Research Design and Approach

• 3.2 Primary Research (Orthopedic Surgeons Specialized in Knee Replacement, Hospital Procurement Managers, Medical Device Distributors, Physical Therapists, KOL Interactions)

• 3.3 Secondary Research (Annual Reports, FDA 510(k)/PMA Medical Device Databases, WHO Global Health Observatory, CDC Orthopedic Reports, AAOS Annual Meeting Data, AHRQ, CMS Bundled Payment CJR Model Publications, The Journal of Arthroplasty, Journal of Knee Surgery, ISTA Publications, European Knee Associates Data)

• 3.4 Top-Down and Bottom-Up Estimation Approach

• 3.5 Data Triangulation and Validation

• 3.6 Market Forecast Assumptions and Key Parameters

4. Market Overview

• 4.1 Introduction to Knee Replacement and Its Role in Restoring Mobility and Reducing Chronic Pain

• 4.2 Historical Market Background and Evolution (Hinged Prosthetics → Cemented TKR → Cementless Fixation → Robotic-Assisted Arthroplasty → Smart Knee Implants)

• 4.3 Market Scope and Definition

• 4.4 Parent Market and Adjacent Market Analysis (Orthopedic Implants, Joint Reconstruction, Sports Medicine, Minimally Invasive Surgery, Orthobiologics)

• 4.5 Regulatory Overview (FDA 510(k)/PMA Clearance, EU MDR 2017/745, ISO 14630 Non-Active Surgical Implants, ASTM F2083, CDSCO Medical Device Rules 2017, NMPA, CMS Bundled Payment CJR Model, Mandatory Patient-Reported Outcome Measures — PROMs 2025 Mandate)

• 4.6 Technology and Innovation Timeline (Traditional TKR → Computer-Assisted Navigation → Robot-Assisted Mako SmartRobotics → AI-Driven Patient-Specific Instrumentation → Smart Sensor-Embedded Implants)

• 4.7 Total Knee Replacement vs. Partial Knee Replacement vs. Revision Arthroplasty: Clinical Outcomes, Recovery Timelines, and Patient Selection Comparison

• 4.8 Robotic-Assisted vs. Conventional Knee Replacement Surgery: Precision, Cost, and Long-Term Outcome Analysis

5. Market Dynamics

• 5.1 Market Drivers

  • 5.1.1 Rising Global Prevalence of Osteoarthritis — WHO 2023 Reports 365 Million People Affected Globally, with Knee as the Most Frequently Impacted Joint

  • 5.1.2 Rapidly Aging Global Population Driving Exponential Increase in Age-Related Degenerative Knee Conditions and Arthroplasty Demand

  • 5.1.3 Growing Epidemic of Obesity and Sedentary Lifestyle Accelerating Knee Joint Deterioration in Younger Demographics (BMI-Related TKR in Under-60s)

  • 5.1.4 Rapid Adoption of Robotic-Assisted Knee Arthroplasty — Stryker Mako SmartRobotics (1.5M+ Procedures Globally Across 45 Countries)

  • 5.1.5 Increasing Awareness About Knee Replacement as Definitive Treatment for Chronic Knee Pain — Growing Patient Empowerment and Physician Referral Rates

  • 5.1.6 Technological Innovation in Implant Materials and Design — Ceramic-on-Ceramic Bearings, Cementless Fixation, and Personalized Knee Systems

  • 5.1.7 Growing Number of Knee Replacement Surgeries in the U.S. (600,000+ Annually per AHRQ) and Across Emerging Economies (India, China, Brazil)

• 5.2 Market Restraints

  • 5.2.1 High Cost of Knee Replacement Surgery (USD 2,500–USD 15,000+ per Procedure) Limiting Adoption in Low- and Middle-Income Economies

  • 5.2.2 Risk of Post-Surgical Complications (Implant Loosening, Deep Vein Thrombosis, Periprosthetic Joint Infection, Stiffness) Reducing Patient Confidence

  • 5.2.3 Prolonged Recovery and Rehabilitation Period Post-Surgery Deterring Elective Procedure Adoption Among Active Working-Age Patients

  • 5.2.4 U.S.-China Tariff Escalation (Up to 145% Duties on Chinese Components) Increasing Manufacturing Costs and Delaying Implant Product Timelines

  • 5.2.5 Limited Availability of Skilled Orthopedic Surgeons and Robotic Surgical Infrastructure in Developing Regions

• 5.3 Market Opportunities

  • 5.3.1 AI-Powered Robotic-Assisted Surgery — Singapore Alexandra Hospital's World-First AI Algorithm for rTKR Granted PCT International Patent (February 2026)

  • 5.3.2 Smart Knee Implants with Embedded Sensors for Remote Patient Monitoring and Rehabilitation Tracking (Zimmer Biomet Persona IQ Smart Knee)

  • 5.3.3 Patient-Specific Instrumentation (PSI) and 3D-Printed Custom Knee Implants for Personalized Fit and Superior Long-Term Outcomes

  • 5.3.4 Surge in Revision Knee Arthroplasty — Growing Pool of Young Active TKR Recipients Needing Revision Procedures as Implant Lifespans Are Exceeded

  • 5.3.5 Expansion of Ambulatory Surgical Centers (ASCs) — Payer Incentives for Outpatient TKR, Zimmer Biomet ZBX ASC Solutions, and High-Turnover Outpatient Knee Care Models

  • 5.3.6 Rapid Growth of Medical Tourism for Affordable Knee Replacement in India, Thailand, Malaysia (7.3 Million Medical Tourists to India in 2024 per CRISIL)

  • 5.3.7 Value-Based Care Shift — CMS CJR Bundled Payment Model and EU MDR PROM Mandates Favoring Cost-Effective, Outcome-Driven Implant Solutions

• 5.4 Market Challenges

  • 5.4.1 Navigating EU MDR 2017/745 Compliance Costs and Streamlined Certification Timelines While Managing Reimbursement Uncertainty Across EU5 Markets

  • 5.4.2 Managing Rising Implant Price Inflation (15–20% Projected) Amid Global Trade Tensions, Tariff Escalation, and Medtech R&D Budget Contractions

  • 5.4.3 Ensuring Long-Term Implant Durability and Performance Consistency Across Diverse Patient Profiles — BMI, Age, Activity Level, and Bone Quality Variability

  • 5.4.4 Addressing Racial, Gender, and Socioeconomic Disparities in Knee Replacement Access, Surgical Outcomes, and Post-Operative Rehabilitation Resources

6. Market Trends and Key Insights

• 6.1 Robotic-Assisted Knee Arthroplasty Enters Mainstream — Stryker Mako SmartRobotics Showcased at AAOS 2025 as Global Standard with 1.5M+ Procedures Performed

• 6.2 Smart Knee Implants Revolutionizing Post-Operative Care — Zimmer Biomet Persona IQ Sensor-Embedded System Monitoring Real-Time Motion Data Post-Surgery

• 6.3 AI-Driven Surgical Planning Platforms Enabling Hyper-Personalized TKR — Singapore rTKR AI Algorithm (February 2026), FDA-Cleared Patient-Specific Planning Pipelines

• 6.4 Cementless Fixation Gaining Momentum — Zimmer Biomet Oxford Cementless Partial Knee FDA Approval (November 2024) as the Only Cementless PKR Implant in the U.S.

• 6.5 Outpatient and ASC-Based TKR Shifting Institutional Dynamics — ZBX ASC Solutions and CMS Reimbursement Reforms Accelerating Same-Day Discharge Models

• 6.6 Younger Patient Demographics Driving Demand for High-Durability, High-Activity Implant Systems — Mobile Bearing and Ceramic-on-Ceramic Segments Benefiting

• 6.7 Strategic M&A Reshaping the Competitive Landscape — Johnson & Johnson KINCISE 2 System Launch (June 2025), Smith & Nephew Orthopaedic Reconstruction Portfolio at AAOS 2025

• 6.8 Expansion of Value-Based and Bundled Payment Models Across the U.S. and Europe Reshaping Procurement and Implant Selection Criteria

7. Impact Assessment

• 7.1 Impact of COVID-19 on the Knee Replacement Market

  • 7.1.1 Pre-COVID Market Scenario

  • 7.1.2 Pandemic Impact: CMS Classified Knee Replacement as Non-Urgent (Tier 2a), Massive Elective Procedure Volume Drop, Revenue Decline for Major Players

  • 7.1.3 Post-COVID Recovery: Pent-Up Procedure Volume Backlog, ASC Expansion, Telemedicine-Linked Pre-Operative Consultation Growth

• 7.2 Macroeconomic Indicators and Their Influence on Market Growth

• 7.3 Impact of CMS CJR Bundled Payment Model, EU MDR PROM Mandate, FDA LDT Rule Revisions, and Global Implant Price Regulation on Market Access

• 7.4 Geopolitical Factors — U.S.-China Tariff Escalation (145% Duties), EU-U.S. Retaliatory Trade Measures on Device Exports, and Asia Pacific Manufacturing Regionalization Strategies

8. Strategic Framework Analysis

• 8.1 Value Chain Analysis

  • 8.1.1 Raw Material Suppliers (Cobalt-Chromium Alloys, Titanium, Medical-Grade Polyethylene, Ceramic Alumina, Hydroxyapatite Coatings)

  • 8.1.2 Implant Component Manufacturers (Femoral, Tibial, and Patellar Component Precision Machining)

  • 8.1.3 Robotic and Navigation System Developers (Mako SmartRobotics, VELYS, NAVIO, THINK Surgical TSolution One)

  • 8.1.4 Patient-Specific Instrumentation and 3D Printing Solution Providers (Conformis, THINK Surgical AI Platform)

  • 8.1.5 Distribution, Sterilization, and Surgical Kit Packaging Partners

  • 8.1.6 Healthcare Delivery Network — Hospitals, ASCs, Orthopedic Clinics, Rehabilitation Centers

  • 8.1.7 Payers, CMS, National Health Systems, and Health Technology Assessment (HTA) Bodies

• 8.2 Supply Chain Analysis and Risk Assessment (Cobalt-Chrome Sourcing, Tariff Impact on Chinese Components, Cold-Chain Implant Logistics)

• 8.3 Porter's Five Forces Analysis

  • 8.3.1 Threat of New Entrants (AI-Native Orthopedic Startups, DTC Patient-Specific Implant Innovators)

  • 8.3.2 Bargaining Power of Buyers (Hospital GPOs, National Health Systems, CMS Bundled Payment Participants)

  • 8.3.3 Bargaining Power of Suppliers (Cobalt-Chrome and Titanium Alloy Manufacturers, Robotic System Component Makers)

  • 8.3.4 Threat of Substitute Therapies (Viscosupplementation, PRP Injections, Regenerative Biologics, Knee Bracing and Physical Therapy)

  • 8.3.5 Competitive Rivalry Among Existing Players

• 8.4 SWOT Analysis of the Overall Market

• 8.5 Pricing Analysis and Trends by Procedure, Implant Type, and Region (USD 2,500–USD 15,000+ per Procedure Range)

• 8.6 Technology Landscape and Innovation Matrix

  • 8.6.1 Robotic-Assisted Knee Arthroplasty — Stryker Mako SmartRobotics, J&J VELYS Robotic-Assisted Solution, Smith & Nephew NAVIO, THINK Surgical TSolution One

  • 8.6.2 AI-Driven Surgical Planning and Real-Time Intraoperative Guidance — Patient-Specific Surgical Planning Algorithms

  • 8.6.3 Smart Sensor-Embedded Knee Implants — IoT-Connected Implants for Remote Post-Operative Monitoring (Persona IQ Smart Knee)

  • 8.6.4 Patient-Specific Instrumentation (PSI) and 3D-Printed Custom Implant Systems (Conformis iTotal System)

  • 8.6.5 Advanced Bearing Materials — Ceramic-on-Ceramic, Highly Cross-Linked Polyethylene (HXLPE), Cementless Biologic Fixation Coatings

  • 8.6.6 Augmented Reality (AR) and Computer-Assisted Navigation for Intraoperative Knee Alignment

• 8.7 IP and Patent Landscape (Key Robotic Navigation, Sensor-Embedded Implant, and PSI Patent Clusters — Zimmer Biomet, Stryker, J&J)

• 8.8 M&A Activity, Strategic Partnerships, and Investment Landscape (2022–2026)

• 8.9 Regulatory and Standards Landscape by Region (FDA 510(k)/PMA, EU MDR 2017/745, ISO 14630, ASTM F2083, CMS CJR, CDSCO, NMPA, PMDA)

• 8.10 Drivers Impact Analysis on CAGR

9. Global Knee Replacement Market — By Procedure

• 9.1 Overview and Market Size, 2026–2033

• 9.2 Total Knee Replacement (TKR) / Total Knee Arthroplasty (TKA)

  • 9.2.1 Conventional Cemented TKR

  • 9.2.2 Cementless / Press-Fit Biologic Fixation TKR

  • 9.2.3 Robotic-Assisted TKR (Mako SmartRobotics, VELYS, THINK Surgical TSolution One)

  • 9.2.4 Minimally Invasive TKR

  • 9.2.5 Market Size, Share, and Forecast (61.6% Dominant Share in 2026 per CMI: Aging Population, Widespread Clinical Guideline Acceptance, Robotic Procedure Growth)

• 9.3 Partial Knee Replacement (PKR) / Unicompartmental Knee Arthroplasty (UKA)

  • 9.3.1 Medial Compartment UKA

  • 9.3.2 Lateral Compartment UKA

  • 9.3.3 Patellofemoral Replacement

  • 9.3.4 Cementless PKR (Oxford Cementless Partial Knee — FDA Cleared November 2024)

  • 9.3.5 Market Size, Share, and Forecast (Significant CAGR: Patient Preference for Faster Recovery, Tissue-Sparing Approach, Growing Young Patient Cohort)

• 9.4 Kneecap Replacement (Patellofemoral Arthroplasty)

  • 9.4.1 Market Size, Share, and Forecast

  • 9.4.2 Key Applications: Isolated Patellofemoral OA, Trochlear Dysplasia, Failed Patellofemoral Bracing

• 9.5 Revision Knee Arthroplasty

  • 9.5.1 Femoral and Tibial Component Revision

  • 9.5.2 Full Implant Revision (Complex / Constrained Systems)

  • 9.5.3 KINCISE 2 System for Automated Knee and Hip Revision — J&J MedTech (Launch June 2025)

  • 9.5.4 Market Size, Share, and Forecast (Fastest Growing Procedure: Young Active Patient Implant Lifespan Expiry, Periprosthetic Infection, and Aseptic Loosening)

10. Global Knee Replacement Market — By Implant Type

• 10.1 Overview and Market Size, 2026–2033

• 10.2 Fixed-Bearing Implants

  • 10.2.1 Posterior Cruciate-Retaining (PCR) Fixed-Bearing

  • 10.2.2 Posterior-Stabilized (PS) Fixed-Bearing

  • 10.2.3 Constrained / Hinged Fixed-Bearing (Complex and Revision Applications)

  • 10.2.4 Market Size, Share, and Forecast (Established Clinical Track Record: Long-Term Durability, Broad Surgeon Familiarity, Cost Efficiency)

• 10.3 Mobile-Bearing Implants

  • 10.3.1 Rotating Platform Mobile-Bearing

  • 10.3.2 Meniscal-Bearing (Oxford Mobile-Bearing UKA)

  • 10.3.3 Market Size, Share, and Forecast (51.12% Dominant Share in 2026 per CMI: Superior Range of Motion, Lower Shear Stress, Material Advancements)

• 10.4 Medial Pivot Implants

  • 10.4.1 Market Size, Share, and Forecast

  • 10.4.2 Key Clinical Benefit: Enhanced Rotational Stability and Natural Kinematic Replication of Native Knee Joint

• 10.5 Others (Customized and Patient-Specific Implants — Conformis iTotal, 3D-Printed Personalized Implant Systems)

  • 10.5.1 Market Size, Share, and Forecast (Growing Premium Niche: Younger Active Patients, Anatomically Complex Cases, High Activity Demand)

11. Global Knee Replacement Market — By Material

• 11.1 Overview and Market Size, 2026–2033

• 11.2 Metal-on-Plastic (Metal-on-Polyethylene)

  • 11.2.1 Cobalt-Chromium Alloy Femoral Component on UHMWPE Tibial Insert

  • 11.2.2 Titanium Alloy with Highly Cross-Linked Polyethylene (HXLPE) Insert

  • 11.2.3 Market Size, Share, and Forecast (Historically Dominant: Well-Established Clinical Evidence, Cost-Effectiveness, Wide Availability)

• 11.3 Ceramic-on-Plastic

  • 11.3.1 Alumina Ceramic Femoral Component on HXLPE Tibial Insert

  • 11.3.2 Market Size, Share, and Forecast (Growing Preference: Reduced Metal Ion Sensitivity, Biocompatibility, Ideal for Patients with Metal Allergy)

• 11.4 Ceramic-on-Ceramic

  • 11.4.1 Alumina Zirconia Toughened Ceramic (AZTEC) Bearing Surfaces

  • 11.4.2 Market Size, Share, and Forecast (50.13% Dominant Share in 2026 per CMI: Lowest Friction Coefficient, Negligible Wear Particulate, Zero Osteolysis Risk Over 15+ Years)

• 11.5 Metal-on-Metal

  • 11.5.1 Market Size, Share, and Forecast (Declining Segment: Regulatory Concerns Over Metal Ion Release, Post-Market Surveillance Mandates)

  • 11.5.2 Key Status: Largely Phased Out for Primary TKR; Residual Use in Select Complex Revision Cases

12. Global Knee Replacement Market — By End User

• 12.1 Overview and Market Size, 2026–2033

• 12.2 Hospitals

  • 12.2.1 Academic Medical Centers and Tertiary Care Hospitals

  • 12.2.2 Community Hospitals with Orthopedic Surgical Programs

  • 12.2.3 Market Size, Share, and Forecast (Dominant End User: Advanced Infrastructure, CSSD Integration, Complex Revision and Robotic Surgery Capabilities, CMS Bundled Care Compliance)

• 12.3 Orthopedic Clinics

  • 12.3.1 Specialty Orthopedic and Musculoskeletal Clinics

  • 12.3.2 Sports Medicine and Joint Reconstruction Clinics

  • 12.3.3 Market Size, Share, and Forecast (Notable CAGR: Rising Specialist Clinic Count, Patient-Centric Orthopedic Care Models)

• 12.4 Ambulatory Surgical Centers (ASCs)

  • 12.4.1 General Multi-Specialty ASCs

  • 12.4.2 Orthopedic-Dedicated ASCs (ZBX ASC Solutions — Zimmer Biomet)

  • 12.4.3 Market Size, Share, and Forecast (Fastest Growing End User: Payer Incentives for Outpatient Arthroplasty, Same-Day Discharge TKR, CMS ASC Coverage Expansion)

• 12.5 Others

  • 12.5.1 Rehabilitation Centers and Long-Term Care Facilities

  • 12.5.2 Military and Defense Medical Facilities

  • 12.5.3 Market Size, Share, and Forecast

13. Global Knee Replacement Market — By Region

• 13.1 Market Overview by Geography

• 13.2 North America

  • 13.2.1 Market Size and Forecast (50.75% Dominant Share in 2025 — USD 4.76 Billion; USD 4.96 Billion in 2026 per FBI)

  • 13.2.2 United States (~USD 4.52 Billion in 2026 — 600,000+ Annual TKR Procedures, 14 Million Symptomatic OA Patients, Mako Robotic Leadership, CMS CJR)

  • 13.2.3 Canada

  • 13.2.4 Mexico

  • 13.2.5 Key Drivers, Trends, and Market Dynamics

• 13.3 Europe

  • 13.3.1 Market Size and Forecast (19.53% Share in 2025 — USD 1.83 Billion; USD 1.92 Billion in 2026 per FBI)

  • 13.3.2 Germany (~USD 0.54 Billion in 2026 — Largest European Market, Digital Health Integration, AI Navigation Systems)

  • 13.3.3 United Kingdom (~USD 0.22 Billion in 2026 — NHS Waiting List Reduction Program, NAVIO Robotic Expansion)

  • 13.3.4 France

  • 13.3.5 Italy

  • 13.3.6 Spain

  • 13.3.7 Russia

  • 13.3.8 Rest of Europe

  • 13.3.9 Key Drivers, Trends, and Market Dynamics (EU MDR PROM Mandate, National Arthroplasty Registry Compliance)

• 13.4 Asia Pacific

  • 13.4.1 Market Size and Forecast (20.44% Share in 2025 — USD 1.91 Billion; USD 2.02 Billion in 2026; Fastest Growing Region)

  • 13.4.2 Japan (~USD 0.71 Billion in 2026 — Aging Population, PMDA Minimally Invasive TKR, Robotic Technique Adoption)

  • 13.4.3 China (~USD 0.61 Billion in 2026 — NMPA Reforms, Rising Disposable Incomes, Medical Tourism, Domestic Implant Innovation)

  • 13.4.4 India (~USD 0.14 Billion in 2026 — CDSCO Approvals, Medical Tourism 7.3M Arrivals 2024, Affordable TKR Hub)

  • 13.4.5 South Korea (K-BIO Medical Technology Initiative, Growing Robotic Surgery Adoption)

  • 13.4.6 Australia and New Zealand

  • 13.4.7 ASEAN (Thailand, Malaysia ~3.8% CAGR, Vietnam)

  • 13.4.8 Rest of Asia Pacific

  • 13.4.9 Key Drivers, Trends, and Market Dynamics

• 13.5 Latin America

  • 13.5.1 Market Size and Forecast (5.94% Share in 2025 — USD 0.56 Billion; USD 0.58 Billion in 2026)

  • 13.5.2 Brazil (Growing Private Orthopedic Infrastructure, São Paulo and Rio Robotic TKR Adoption)

  • 13.5.3 Mexico

  • 13.5.4 Argentina

  • 13.5.5 Rest of Latin America

  • 13.5.6 Key Drivers, Trends, and Market Dynamics

• 13.6 Middle East & Africa

  • 13.6.1 Market Size and Forecast (3.35% Share in 2025 — USD 0.31 Billion; USD 0.33 Billion in 2026)

  • 13.6.2 GCC Countries (Saudi Arabia, UAE, Kuwait — Government Healthcare Expansion, NIDCenter Investment)

  • 13.6.3 Israel

  • 13.6.4 South Africa

  • 13.6.5 North Africa and Central Africa

  • 13.6.6 Rest of Middle East & Africa

  • 13.6.7 Key Drivers, Trends, and Market Dynamics

14. Competitive Landscape

• 14.1 Market Structure and Competitiveness Overview (Moderately Concentrated: Zimmer Biomet, Stryker, J&J DePuy Synthes as Dominant Leaders; Top 4 Players Hold Over 75% Global Revenue)

• 14.2 Market Share Analysis of Key Players

• 14.3 Competitive Positioning Matrix

• 14.4 Key Strategies Adopted by Market Leaders

  • 14.4.1 Robotic Platform Leadership and AAOS Showcase — Stryker Mako SmartRobotics (1.5M+ Procedures, 45 Countries), J&J VELYS, Smith & Nephew NAVIO

  • 14.4.2 Smart Implant and IoT Integration — Zimmer Biomet Persona IQ Smart Knee with Post-Surgical Motion Monitoring and PCT-Protected AI Algorithm

  • 14.4.3 Cementless and Next-Generation Product Launches — Oxford Cementless Partial Knee FDA Clearance (November 2024), Persona Revision SoluTion Femur (AAOS March 2026)

  • 14.4.4 ASC and Outpatient TKR Strategy — ZBX ASC Portfolio, CMS CJR Compliance Consulting Support for Hospital and ASC Partners

  • 14.4.5 Emerging Market Expansion — Medical Tourism Partnerships (India, Thailand, Malaysia), Domestic Manufacturing Alliances in China and South Korea

• 14.5 Recent Developments and Industry News (2024–2026)

• 14.6 Technology and Product Pipeline Analysis

15. Company Profiles
(The final report includes a complete list of companies)

• 15.1 Zimmer Biomet Holdings, Inc.

  • 15.1.1 Company Overview

  • 15.1.2 Financial Performance

  • 15.1.3 Product Portfolio

  • 15.1.4 Strategic Initiatives

  • 15.1.5 SWOT Analysis

• 15.2 Stryker Corporation

• 15.3 DePuy Synthes (Johnson & Johnson MedTech)

• 15.4 Smith & Nephew plc

• 15.5 B. Braun Melsungen AG (Aesculap)

• 15.6 Medacta International SA

• 15.7 MicroPort Scientific Corporation

• 15.8 Conformis, Inc.

• 15.9 DJO Global, Inc.

• 15.10 Exactech, Inc.

• 15.11 Corin Group

• 15.12 Waldemar LINK GmbH & Co. KG

• 15.13 Arthrex, Inc.

• 15.14 THINK Surgical, Inc.

• 15.15 Medtronic plc

16. Appendix

• 16.1 Abbreviations and Acronyms

• 16.2 List of Tables

• 16.3 List of Figures

• 16.4 About the Publisher

• 16.5 Research Process and Data Sources

17. Disclaimer